Pinnacle Biologics, Inc.

pinnaclebiologics.com

Pinnacle Biologics specializes in revitalizing healthcare therapies by promoting, developing and managing innovative approaches to the global commercialization of products in the oncology and specialty areas.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights, PHARMA TECH

XTALPI PARTNERS WITH SINGAPORE'S DRUG DISCOVERY PLATFORM TO FIND BETTER CANCER TREATMENTS

XtalPi Inc. | December 29, 2022

news image

One of the pioneering pharmaceutical technology companies - XtalPi, powered by artificial intelligence (AI) and automation, has recently announced a strategic collaboration with Singapore's national platform for drug discovery and development, the Experimental Drug Development Centre (EDDC), which is hosted by the Agency for Science, Technology, and Research of Singapore (A*STAR). The goal of this partnership is to find novel treatment candidates for non-small cell lung cancer (NSCLC)....

Read More

Business Insights

ASYMCHEM ACQUIRES SNAPDRAGON CHEMISTRY

Asymchem | February 14, 2022

news image

Asymchem Laboratories Co., Ltd. a leading CDMO serving the global pharmaceutical and biotech industry, today announced its agreement to acquire Snapdragon Chemistry, Inc., a US-based chemical technology company providing industry-leading expertise in continuous manufacturing and early-stage chemical process development services to the pharmaceutical and fine chemical industries for US $57.94 million. This addition will significantly expand Asymchem's footprint in the US, offering customers a...

Read More

Business Insights

FDA ACCEPTS DUPIXENT® (DUPILUMAB) FOR PRIORITY REVIEW IN ADULTS WITH PRURIGO NODULARIS

Regeneron Pharmaceuticals, Inc. | May 31, 2022

news image

Regeneron Pharmaceuticals, Inc. and Sanofi announced that the U.S. Food and Drug Administration has accepted for Priority Review the supplemental Biologics License Application (sBLA) for Dupixent® Medical (dupilumab) to treat adults with prurigo nodularis, a chronic skin disease that causes extreme itch and inflammatory skin lesions. The target action date for the FDA decision is September 30, 2022. The sBLA is supported by data from two pivotal Phase 3 trials evaluating the e...

Read More

US WILL BE WORLD'S PREMIER PHARMACY DRUG STORE AND MEDICAL MANUFACTURER: TRUMP

cnbctv18 | May 21, 2020

news image

The COVID-19 pandemic has proven once and for all that to be a strong nation, America must be a manufacturing nation, US President Donald Trump said on Thursday declaring the goal of making his country the world's premier pharmacy, drug store, and medical manufacturer. "The global pandemic has proven once and for all that to be a strong nation, America must be a manufacturing nation.... Today, I'm declaring a simple but vital national goal. The United States will be the world's ...

Read More
news image

Business Insights, PHARMA TECH

XTALPI PARTNERS WITH SINGAPORE'S DRUG DISCOVERY PLATFORM TO FIND BETTER CANCER TREATMENTS

XtalPi Inc. | December 29, 2022

One of the pioneering pharmaceutical technology companies - XtalPi, powered by artificial intelligence (AI) and automation, has recently announced a strategic collaboration with Singapore's national platform for drug discovery and development, the Experimental Drug Development Centre (EDDC), which is hosted by the Agency for Science, Technology, and Research of Singapore (A*STAR). The goal of this partnership is to find novel treatment candidates for non-small cell lung cancer (NSCLC)....

Read More
news image

Business Insights

ASYMCHEM ACQUIRES SNAPDRAGON CHEMISTRY

Asymchem | February 14, 2022

Asymchem Laboratories Co., Ltd. a leading CDMO serving the global pharmaceutical and biotech industry, today announced its agreement to acquire Snapdragon Chemistry, Inc., a US-based chemical technology company providing industry-leading expertise in continuous manufacturing and early-stage chemical process development services to the pharmaceutical and fine chemical industries for US $57.94 million. This addition will significantly expand Asymchem's footprint in the US, offering customers a...

Read More
news image

Business Insights

FDA ACCEPTS DUPIXENT® (DUPILUMAB) FOR PRIORITY REVIEW IN ADULTS WITH PRURIGO NODULARIS

Regeneron Pharmaceuticals, Inc. | May 31, 2022

Regeneron Pharmaceuticals, Inc. and Sanofi announced that the U.S. Food and Drug Administration has accepted for Priority Review the supplemental Biologics License Application (sBLA) for Dupixent® Medical (dupilumab) to treat adults with prurigo nodularis, a chronic skin disease that causes extreme itch and inflammatory skin lesions. The target action date for the FDA decision is September 30, 2022. The sBLA is supported by data from two pivotal Phase 3 trials evaluating the e...

Read More
news image

US WILL BE WORLD'S PREMIER PHARMACY DRUG STORE AND MEDICAL MANUFACTURER: TRUMP

cnbctv18 | May 21, 2020

The COVID-19 pandemic has proven once and for all that to be a strong nation, America must be a manufacturing nation, US President Donald Trump said on Thursday declaring the goal of making his country the world's premier pharmacy, drug store, and medical manufacturer. "The global pandemic has proven once and for all that to be a strong nation, America must be a manufacturing nation.... Today, I'm declaring a simple but vital national goal. The United States will be the world's ...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us